Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.48 |
| ▸ | GPR3 | P46089 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17739606 | 0.88 | GPR3 (0.57) | MAOAMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL17694641 | 0.82 | LMNA (0.48) | ALDH1A1GPR3 | |
| SCHEMBL4730115 | 0.82 | MEN1 (0.41) | MAOAMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL12146999 | 0.81 | GPR3 (0.57) | MAOAMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL14087383 | 0.81 | LMNA (0.52) | MAOAMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL188872 | 0.79 | ELANE (0.57) | MAOAMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL31472931 | 0.78 | GPR3 (0.75) | MAOAMEN1KMT2AALDH1A1CHEK1 | |
| SCHEMBL472539 | 0.78 | GPR3 (0.75) | MAOAMEN1KMT2AALDH1A1CHEK1 | |
| SCHEMBL29368441 | 0.78 | GPR3 (0.75) | MAOAMEN1KMT2AALDH1A1CHEK1 | |
| SCHEMBL11635548 | 0.78 | ELANE (0.58) | MAOAMEN1KMT2AALDH1A1CHEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008061029-A1 | ARYL SULFONAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-05-22 | — | — | WO | disclosed |